| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |